NCT05191563View on ClinicalTrials.gov

A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination of HCP1904 and Co-Administration of RLD2001-2 and RLD2006 Tablets in Healthy Subjects.

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

July 31, 2021

Primary Completion Date

September 12, 2021

Study Completion Date

September 12, 2021

Conditions
Healthy
Interventions
DRUG

HCP1904-1

Take it once per period.

DRUG

RLD2006

Take it once per period.

DRUG

RLD2001-2

Take it once per period.

Trial Locations (1)

Unknown

Yangji Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT05191563 - A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination of HCP1904 and Co-Administration of RLD2001-2 and RLD2006 Tablets in Healthy Subjects. | Biotech Hunter | Biotech Hunter